Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Hematology

Recognizing Bleeds and Warning Signs

At a Glance

The most critical step in managing Hemophilia A is recognizing a bleed early. Watch for an "aura" like tingling or warmth in joints, and always immediately treat suspected head, neck, or trunk bleeds with Factor VIII before seeking emergency care.

Identifying a bleed early is the most important skill for a patient or caregiver living with Hemophilia A. Because internal bleeding is not always visible, learning to “listen” to the body’s signals allows for faster treatment and prevents long-term damage to joints and tissues [1][2].

Early Warning Signs: The “Aura”

In many cases, a person with hemophilia can feel a bleed starting before any swelling or bruising appears. This is often called an aura.

  • Tingling or Bubbling: A strange, “fizzy,” or tingling sensation deep inside a joint.
  • Warmth: The area may feel slightly warmer to the touch than the surrounding skin.
  • Tightness: A feeling of “fullness” or pressure, as if the joint needs to be stretched, though stretching does not help.

Types of Bleeds

Bleeding in Hemophilia A typically happens internally, into spaces like joints and muscles. While factor replacement is the primary treatment, applying ice, rest, and elevation (the RICE protocol) can be a helpful comfort measure for acute joint or muscle bleeds, provided it does not delay the infusion.

1. Joint Bleeds (Hemarthrosis)

This is the most common type of bleed, especially in severe hemophilia [3][4].

  • Signs: Increasing pain, swelling, and a loss of the ability to fully move or straighten the limb (decreased range of motion).
  • Target Joints: Bleeds most often occur in the knees, elbows, and ankles. If a joint bleeds repeatedly, it is called a “target joint” and can lead to permanent arthritis [5].

2. Muscle Bleeds

Muscle bleeds can be more deceptive than joint bleeds because the blood is contained within a large muscle group.

  • Signs: The muscle feels hard, tight, or very painful when moved or touched.
  • Risk: If the swelling is severe, it can press on nerves or blood vessels, causing a dangerous condition called compartment syndrome [6][7].

3. Surface Bleeds and Bruising

While large, “lumpy” bruises (hematomas) are common, simple scrapes or small cuts usually do not cause major problems for people with hemophilia [8].

Severity and Presentation

The frequency and triggers for bleeding depend heavily on your Factor VIII activity levels:

  • Severe (<1% Factor): Bleeding is often spontaneous, meaning it can happen during normal daily activities or even while sleeping [9][10].
  • Moderate (1–5% Factor): Bleeds usually follow a specific minor injury, such as a fall or a bump.
  • Mild (5–40% Factor): Bleeds are rare and typically only happen after a major injury, surgery, or dental procedure [11]. Many people with mild hemophilia go undiagnosed for decades because they do not have a “spontaneous” bleeding history [12][13].

Emergency Warning Signs

Certain bleeds are medical emergencies and require immediate treatment, even before going to the hospital or getting an X-ray [14].

Bleed Location Warning Signs
Head (Intracranial) Severe headache, nausea, vomiting, sleepiness, or confusion [15].
Neck or Throat Swelling in the neck, difficulty swallowing, or trouble breathing.
Gastrointestinal Vomiting blood (may look like coffee grounds) or black, tarry stools [16].
Iliopsoas (Deep Hip) Severe pain in the groin or lower back; inability to straighten the leg on that side.

Important Rule: If you suspect a head, neck, or trunk bleed, infuse first and then seek emergency care [14][17]. Rapid treatment is the most effective way to stop a life-threatening hemorrhage [18].

Note for patients on Emicizumab (Hemlibra) or other non-factor therapies: Your routine subcutaneous shot is a preventative medication, not a rescue medication. In an emergency, you must use standard Factor VIII or a bypassing agent as directed by your care team to stop an active bleed.

Be Prepared: Always carry a medical alert bracelet, a travel letter from your Hemophilia Treatment Center, or a digital medical ID on your phone. This information should outline your baseline severity, current prophylactic treatment, and your hematologist’s contact information so emergency responders know exactly how to treat you if you are unable to speak. Patients taking emicizumab must alert emergency rooms that standard aPTT tests will look artificially normal and cannot be trusted to guide treatment [19].

Common questions in this guide

What does a hemophilia joint bleed feel like?
A joint bleed often starts with an "aura" characterized by a tingling, bubbling, or warm sensation deep inside the joint. As the bleed progresses, it causes increasing pain, swelling, and an inability to fully move or straighten the limb.
How can I tell the difference between a muscle strain and a deep muscle bleed?
A muscle bleed causes the muscle to feel hard, tight, or intensely painful when touched or moved. Because blood is contained within a large muscle group, severe swelling can dangerously press on nerves or blood vessels, making prompt treatment essential.
What should I do if I suspect a head injury or head bleed?
A suspected head bleed is a life-threatening medical emergency. You should immediately infuse your rescue factor treatment before going to the emergency room or waiting for symptoms like a headache or nausea to appear.
Can I use Emicizumab (Hemlibra) to treat an active bleed?
No, Emicizumab (Hemlibra) is a routine preventative medication, not a rescue therapy. In the event of an active bleed or emergency, you must use standard Factor VIII or a bypassing agent as directed by your care team.
Why do some hemophilia patients bleed from minor injuries while others do not?
Bleeding risks depend on your baseline Factor VIII levels. People with severe hemophilia can experience spontaneous bleeds during normal activities, whereas people with mild hemophilia typically only experience bleeds following major trauma, surgery, or dental work.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my factor levels, what are the most common 'target joints' I should watch for?
  2. 2.How do I distinguish between a regular muscle strain and a deep muscle bleed?
  3. 3.If I have a suspected head injury, should I wait to see symptoms or treat with factor immediately?
  4. 4.For a patient with mild hemophilia, what types of minor trauma should prompt a call to your office?
  5. 5.Can you help me develop a 'Bleed Action Plan' that lists exactly when to call you versus when to go to the ER?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Treatment of Bleeding Episodes With Efanesoctocog Alfa in Previously Treated Patients With Severe Hemophilia A in the Phase 3 XTEND-1 Study.

    Weyand AC, Meunier S, Suzuki N, et al.

    American journal of hematology 2025; (100(5)):813-820 doi:10.1002/ajh.27603.

    PMID: 39927501
  2. 2

    Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.

    von Drygalski A, Chowdary P, Kulkarni R, et al.

    The New England journal of medicine 2023; (388(4)):310-318 doi:10.1056/NEJMoa2209226.

    PMID: 36720133
  3. 3

    Emergency Department Presentation of Iliopsoas Hematoma in a Severe Hemophiliac.

    Burgess A, Douglas D, Grubish L

    The American journal of emergency medicine 2018; (36(3)):529.e3-529.e4 doi:10.1016/j.ajem.2017.12.035.

    PMID: 29277492
  4. 4

    Clinicopathological features of hemophilia in a tertiary care centre of India.

    Pawan PK, Mahima Y, Vijai T, Manjula L

    Journal of family medicine and primary care 2021; (10(1)):295-299 doi:10.4103/jfmpc.jfmpc_1564_20.

    PMID: 34017743
  5. 5

    Hemophilia A with a Rare Presentation of Hemarthrosis and Arthropathy Involving Multiple Joints in a Young Male Child.

    Majid Z, Tahir F, Qadar LT, et al.

    Cureus 2019; (11(4)):e4524 doi:10.7759/cureus.4524.

    PMID: 31259133
  6. 6

    [Acquired hemophilia A associated with chronic myelomonocytic leukemia successfully treated by rituximab and azacitidine].

    Dartevel A, Aubanel S, Pica GM, et al.

    La Revue de medecine interne 2018; (39(8)):654-657 doi:10.1016/j.revmed.2018.03.373.

    PMID: 29653879
  7. 7

    Compartment syndrome of the forearm with life-threatening bleeding after fasciotomy as the presenting sign of postpartum acquired hemophilia A: a case report.

    Van Laer M, Penaloza A, Stockman W, et al.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2019; (30(3)):120-126 doi:10.1097/MBC.0000000000000799.

    PMID: 30864964
  8. 8

    Acquired hemophilia A: Updated review of evidence and treatment guidance.

    Kruse-Jarres R, Kempton CL, Baudo F, et al.

    American journal of hematology 2017; (92(7)):695-705 doi:10.1002/ajh.24777.

    PMID: 28470674
  9. 9

    Acute Life-Threatening Hemorrhage in Neonates With Severe Hemophilia A: A Report of 3 Cases.

    Moreira A, Das H

    Journal of investigative medicine high impact case reports 2018; (6()):2324709618800349 doi:10.1177/2324709618800349.

    PMID: 30246038
  10. 10

    Mutation analysis in the F8 gene in 485 families with haemophilia A and prenatal diagnosis in China.

    Feng Y, Li Q, Shi P, et al.

    Haemophilia : the official journal of the World Federation of Hemophilia 2021; (27(1)):e88-e92 doi:10.1111/hae.14206.

    PMID: 33245802
  11. 11

    [Mild hemophilia A diagnosed in an adult patient on the occasion of post-operative bleeding following a second knee surgery].

    Nakagawa N, Fujinaga M, Chikagawa Y, et al.

    [Rinsho ketsueki] The Japanese journal of clinical hematology 2019; (60(5)):398-400 doi:10.11406/rinketsu.60.398.

    PMID: 31168002
  12. 12

    Congenital hemophilia A diagnosed with postoperative hemorrhage after thyroidectomy for papillary thyroid carcinoma: a case report.

    Saitou M, Okamoto M, Nagaoka R, et al.

    Surgical case reports 2021; (7(1)):189 doi:10.1186/s40792-021-01272-x.

    PMID: 34417909
  13. 13

    Uncontrollable bleeding after tooth extraction from asymptomatic mild hemophilia patients: two case reports.

    Fan G, Shen Y, Cai Y, et al.

    BMC oral health 2022; (22(1)):69 doi:10.1186/s12903-022-02074-9.

    PMID: 35282827
  14. 14

    Management of intracranial hemorrhage in hemophilia A patients.

    Aras M, Oral S

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2020; (36(9)):2041-2046 doi:10.1007/s00381-020-04528-3.

    PMID: 32025871
  15. 15

    Congenital Bleeding Disorders: Managing Central Nervous System Bleeding in an Adult Hemophiliac.

    Dahra A, Mehdi Z, Gupta M, et al.

    Cureus 2023; (15(3)):e36906 doi:10.7759/cureus.36906.

    PMID: 37128522
  16. 16

    Esophageal ulcer associated with mild hemophilia A: case report.

    Nicolescu CM, Neşiu A, Uzum A, et al.

    Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2022; (63(3)):581-585 doi:10.47162/RJME.63.3.14.

    PMID: 36588498
  17. 17

    Successful intraosseous factor VIII application in a haemophilic emergency.

    Banchev A, Stoyanova D, Avramova B, et al.

    Journal of clinical pharmacy and therapeutics 2021; (46(1)):212-214 doi:10.1111/jcpt.13252.

    PMID: 32860636
  18. 18

    Mimicking Factor VIII to Manage the Factor VIII-Deficient State.

    Ragni MV

    The New England journal of medicine 2018; (379(9)):880-882 doi:10.1056/NEJMe1808789.

    PMID: 30157395
  19. 19

    Laboratory issues in gene therapy and emicizumab.

    Bowyer AE, Lowe AE, Tiefenbacher S

    Haemophilia : the official journal of the World Federation of Hemophilia 2021; (27 Suppl 3()):142-147 doi:10.1111/hae.13976.

    PMID: 32469128

This page provides educational information on recognizing Hemophilia A bleeds. It is not a substitute for an emergency action plan or professional medical advice from your hematology care team.

Get notified when new evidence is published on Hemophilia A.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.